mRNA Analytical Services
Why Choose Curia for Your Biologics Analytical Needs?
Curia offers comprehensive platforms for biologics development, manufacturing, and analytics, ensuring seamless support throughout every stage of your project. We provide both GMP and non-GMP testing, specifically tailored for each phase of development. Our team prioritizes close collaboration and transparent communication, enabling you to stay informed and engaged. With on-site analytics, we deliver rapid turnaround times to keep your project moving efficiently. Clients consistently express high satisfaction with our timelines, project management, communication, and delivery. Our integrated approach covers all phases of drug development, including routine early-phase testing and in-process testing for clinical and commercial batch release.
Characterization of antibodies and proteins
- Identity – MS, NMR (1D, 2D), IR, Raman, UV-Vis, Sequencing, AAA
- Purity – U/HPLC (RP, IEX, SEC, chiral), IC, Electrophoresis (Native/SDS-PAGE, IEF, CE)
- Potency – Binding assay, functional assay (ITC, biochemical or cellular assay)
- Structure – Protein crystallography or cryo-EM
- Safety – Endotoxin testing, bioburden, immunogenicity
- Stability
- Comparability
- Aggregation
- Activity and binding assays
Analysis of biochemical drugs
- Isolation, purification, and characterization
- Isolation, purification, and characterization of product/process-related impurities
- Safety assessment
- Biological activity
- Comparability testing
- Stability testing
- Chemical structure assessment
- In vitro and in vivo assays
- Protein and peptide crystallization
Analytical Capabilities for Biologics
